Biomarin Pharmaceutical (BMRN) Q1 2022 Earnings

23FebConfirmed
Q2 2021
Q3 2021
Q4 2021
Q1 2022
-0.33
-0.19
-0.05
0.09

Details

Expected EPS
-0.33
Actual EPS
-0.32
Surprise EPS
0.01
Surprise Percent
+3.03%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of -0.32 per share for Q1 2022.

0 Comments

Share your thoughts